$68.12
0%
Price vs. AI Score (Last 150 days)
Data gathered: December 6
Data gathered: December 6
Data Bits
| Data Bits | Value / Change | Benchmark |
|---|---|---|
| Job Posts | 88 0% |
|
| Sentiment | 96 0% |
|
| Webpage traffic | 38,000 -13.3% |
|
| Employee Rating | 76 0% |
|
| Linkedin Employees | 425 N/A |
|
| 4chan Mentions | 0% | N/A |
| Stocktwits Mentions | 7 -12.5% |
|
| Stocktwits Subscribers | 10,986 -0% |
|
| Twitter Followers | 299 0% |
|
| News Mentions | 0% |
|
| Reddit Mentions | 0% |
|
| Business outlook | 72 0% |
|
In the news
Analysts Offer Insights on Healthcare Companies: Urogen Pharma (URGN), OrthoPediatrics (KIDS) and Axsome Therapeutics (AXSM)December 4 - TipRanks |
|
Maintaining Buy Rating on Axsome: Seasonal Prescription Dip Not a Long-Term ConcernDecember 4 - TipRanks |
|
Piper Sandler Remains a Buy on Axsome Therapeutics (AXSM)November 29 - TipRanks |
|
Analysts Offer Insights on Healthcare Companies: Arcutis Biotherapeutics (ARQT), Axsome Therapeutics (AXSM) and Cytokinetics (CYTK)November 28 - TipRanks |
|
AXSM DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Axsome Therapeutics, Inc. Investors to Secure Counsel Before Important December 7 Deadline in Securities Class Action – AXSMNovember 27 - GlobeNewswire |
|
 |
11 Best Upside Stocks To Buy Right NowNovember 26 - Yahoo |
About Axsome Therapeutics
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States.
| Price | $68.12 |
| Target Price | Sign up |
| Market Cap | $3.25B |
| Dividend Yield | 0 |
| Industry | Biotechnology |
Similar companies
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | |
|---|---|---|---|---|---|
| Q3 '23 | 53M | 91M | -39M | -62M | -56M |
| Q2 '23 | 47M | 85M | -43M | -67M | -62M |
| Q1 '23 | 95M | 83M | 6.8M | -11M | -2.6M |
| Q4 '22 | 24M | 2.3M | -21M | -61M | -56M |
| Q3 '22 | 14M | 1.9M | 12M | -45M | -40M |
Insider Transactions
| Coleman Mark filed to sell 403,856 shares at $75.2. September 15 '23 |
Read more about Axsome Therapeutics and their earnings, price prediction, job posts, sentiment, webpage traffic, employee rating, linkedin employees, 4chan mentions, stocktwits mentions, stocktwits subscribers, twitter followers, news mentions, reddit mentions, business outlook.